Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: Mebeverine hydrochloride
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Mebeverine 135mg tablets
0102000P0AAABAB
|
Mebeverine hydrochloride | Mebeverine hydrochloride | Gastro-Intestinal System | 253,637 |
|
Mebeverine 200mg modified-release capsules
0102000P0AAADAD
|
Mebeverine hydrochloride | Mebeverine hydrochloride | Gastro-Intestinal System | 70,439 |
|
Mebeverine 50mg/5ml oral suspension sugar free
0102000P0AAAAAA
|
Mebeverine hydrochloride | Mebeverine hydrochloride | Gastro-Intestinal System | 2,871 |
|
Mebeverine 135mg oral powder sachets
0102000P0AAAEAE
|
Mebeverine hydrochloride | Mebeverine hydrochloride | Gastro-Intestinal System | 2 |
|
Mebeverine 100mg tablets
0102000P0AAACAC
|
Mebeverine hydrochloride | Mebeverine hydrochloride | Gastro-Intestinal System | No data available |
|
Mebeverine 150mg/5ml oral suspension
0102000P0AAAFAF
|
Mebeverine hydrochloride | Mebeverine hydrochloride | Gastro-Intestinal System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.